Immunic AG | WebDisclosure

PRESS RELEASE

published on 01/07/2026 at 12:30, 2 months 15 days ago

Immunic Highlights 2025 Accomplishments and Upcoming Milestones
Immunic Inc. highlights its 2025 accomplishments & upcoming milestones including phase 3 trials for Vidofludimus Calcium in relapsing Multiple Sclerosis, positive data in Progressive MS, & potential for IMU-856 in weight management

Immunic Inc. Multiple Sclerosis Vidofludimus Calcium IMU-856 2025 Accomplishments
BRIEF

published on 11/26/2025 at 12:35, 3 months 26 days ago

Immunic participera à la conférence Evercore ISI Healthcare en décembre

Biotechnologie Conférence Sur Les Soins De Santé Immunitaire Maladies Neurologiques Réunions Avec Les Investisseurs
BRIEF

published on 11/26/2025 at 12:35, 3 months 26 days ago

Immunic to Join Evercore ISI Healthcare Conference in December

Biotechnology Immunic Investor Meetings Healthcare Conference Neurologic Diseases
PRESS RELEASE

published on 11/26/2025 at 12:30, 3 months 26 days ago

Immunic to Participate in the 8th Annual Evercore ISI Healthcare Conference in December
Immunic to participate in the 8th Annual Evercore ISI Healthcare Conference in December. Dr. Daniel Vitt to speak at fireside chat on novel oral therapies for neurologic and gastrointestinal diseases

Gastrointestinal Diseases Immunic Neurologic Diseases Evercore ISI Healthcare Conference Daniel Vitt
BRIEF

published on 11/13/2025 at 12:35, 4 months 9 days ago

Immunic, Inc. annonce ses résultats financiers et ses mises à jour pour le troisième trimestre 2025

Résultats Financiers Essais Cliniques Sclérose En Plaques Vidofludimus Calcium Immunique, Inc.
BRIEF

published on 11/13/2025 at 12:35, 4 months 9 days ago

Immunic, Inc. Announces Third Quarter 2025 Financial Results and Updates

Financial Results Clinical Trials Immunic, Inc. Multiple Sclerosis Vidofludimus Calcium
PRESS RELEASE

published on 11/13/2025 at 12:30, 4 months 9 days ago

Immunic, Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Immunic, Inc. reports Q3 2025 financial results and provides corporate update, highlighting vidofludimus calcium's therapeutic potential in multiple sclerosis. Phase 3 ENSURE trial data expected by 2026

Financial Results Immunic Inc. Vidofludimus Calcium Phase 3 Trials MS Therapy
BRIEF

published on 10/29/2025 at 11:35, 4 months 24 days ago

Immunic to Participate in Key November Conferences

Biotechnology Immunic Conference Participation BIO-Europe Jefferies Conference
BRIEF

published on 10/29/2025 at 11:35, 4 months 24 days ago

Immunisé pour participer aux principales conférences de novembre

Biotechnologie Conférence Jefferies Participation À La Conférence BIO-Europe Immunique
PRESS RELEASE

published on 10/29/2025 at 11:30, 4 months 24 days ago

Immunic to Participate in Industry and Investor Conferences in November
Immunic, Inc. to participate in industry and investor conferences in November, presenting clinical pipeline of therapies for inflammatory diseases

Investor Conferences Immunic Inc. Clinical Pipeline Inflammatory Diseases Industry Conferences

Published on 03/20/2026 at 23:00, 1 day 18 hours ago

Cypher Announces Private Placement
Published on 03/20/2026 at 21:30, 1 day 19 hours ago

Sky Gold Sets Options
Published on 03/20/2026 at 21:15, 1 day 20 hours ago

Earthwise Minerals Announces Private Placement
Published on 03/20/2026 at 13:30, 2 days 3 hours ago

Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock
Published on 03/20/2026 at 12:30, 2 days 4 hours ago

CANEX Metals Announces the Numbers of Gold Basin Shares Taken up by Canex Metals

View all ACCESSWIRE

Published on 03/22/2026 at 12:23, 4 hours 56 minutes ago

Borussia Dortmund and Sebastian Kehl are ending their collaboration with immediate effect
Published on 03/20/2026 at 22:45, 1 day 18 hours ago

Investor Alert: Berger Montague (Canada) PC represents investors that purchased shares of Super Micro Computer, Inc. listed on the CBOE Canada and elsewhere
Published on 03/20/2026 at 21:05, 1 day 20 hours ago

Fractal EMS Receives ISO/IEC 9001 and 27001 Certifications
Published on 03/20/2026 at 21:05, 1 day 20 hours ago

Nebius Group announces closing of private offering of convertible senior notes, with aggregate gross proceeds of approximately $4.3 billion
Published on 03/20/2026 at 21:00, 1 day 20 hours ago

BRP Unveils the Winners of its 6th International Design Challenge

View all EQS

Published on 03/20/2026 at 19:00, 1 day 22 hours ago

AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 1 day 22 hours ago

AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 1 day 23 hours ago

Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 1 day 23 hours ago

Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
Published on 03/20/2026 at 17:45, 1 day 23 hours ago

Cie du Bois Sauvage : Jaarverslag 2025

View all LES ECHOS COMFI WIRE

News